Armistice Capital »

Aclarion shares owned by Armistice Capital

Quarter-by-quarter ownership of Aclarion (ACONW) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Aclarion

Tip: Access up to 7 years of quarterly data

All positions including Aclarion held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aclarion by Armistice Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.3k 34k 0.04
2024-03-31 $1.2k 34k 0.04
2023-09-30 $41k 550k 0.08
2023-06-30 $44k 550k 0.08
2023-03-31 $39k 550k 0.07
2022-12-31 $85k 550k 0.16
2022-09-30 $209k 550k 0.38

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ptc Therapeutics I (PTCT)
Cytokinetics Com New (CYTK)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Incyte Corporation (INCY)
Immunovant (IMVT)
Agios Pharmaceuticals (AGIO)
Argenx Se Sponsored Adr (ARGX)
Novo-nordisk A S Adr (NVO)
Sanofi Sponsored Adr (SNY)
Alkermes SHS (ALKS)
Medtronic SHS (MDT)
Aurinia Pharmaceuticals (AUPH)

View all positions for Armistice Capital

Top funds holding Aclarion

Captrust Financial Advisors
Clear Street
Citadel Advisors
Armistice Capital

View all funds holding Aclarion